Novacyt (FR:ALNOV) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Novacyt has launched two new multiplex qPCR tests for detecting gastrointestinal diseases in cats and dogs, debuting at the London Vet Show. These tests streamline the detection of six crucial pathogens, offering faster results and efficiency for veterinary laboratories. This innovation aligns with Novacyt’s commitment to enhancing diagnostic solutions in the veterinary sector.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.
